Lab-grown human brain tissue could replicate a supercomputer
Researchers are growing brain tissue that can respond to electrical signals, much like a computer, and could help create a reliable supercomputer, Nature reports.
Researchers are growing brain tissue that can respond to electrical signals, much like a computer, and could help create a reliable supercomputer, Nature reports.
The launch is part of wide-ranging efforts to build up local pharmaceutical capacity and reduce dependence on foreign agencies and companies.
After lobbyists spent big on the Trump administration and Democratic defectors, the government funding bill cut food-contamination rules and limited ultraprocessed-food research.
They got out of the government shutdown with few substantive concessions to Democrats, but they’re diverging on their opponents’ top issue.
The decision comes two decades after saying the drugs could cause cancer in women, with researchers now saying the risks were overstated.
Canada lost its national certification after nearly three decades over a 5,000-case outbreak, while the US is also at risk.
US pharma giant Pfizer won a bidding war to acquire obesity drug developer Metsera, beating back an offer from Danish rival Novo Nordisk.
How drugmakers captured the FDA, what Zohran Mamdani’s win means for democracy, and more from The Lever this week.
Whether or not Congress extends the Affordable Care Act’s enhanced premium tax credits, health care giants are poised to extract new profits from patient pain.